Aptevo Therapeutics Inc.
APVO
$1.85
-$0.04-1.86%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -6.36M | -6.70M | -5.81M | -7.55M | -6.20M |
| Total Depreciation and Amortization | 32.00K | 35.00K | 81.00K | 49.00K | 49.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 328.00K | 328.00K | 1.09M | 77.00K | 110.00K |
| Change in Net Operating Assets | 542.00K | -1.63M | -602.00K | 735.00K | -1.05M |
| Cash from Operations | -5.45M | -7.97M | -5.24M | -6.69M | -7.09M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 726.00K | 872.00K | 5.79M | 18.34M | 14.36M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -1.00K | -- | -- | -- |
| Cash from Financing | 726.00K | 871.00K | 5.79M | 18.34M | 14.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.73M | -7.09M | 558.00K | 11.65M | 7.27M |